Streetbeat News

Products Services

EVO

Evotec and Novo Nordisk have announced a partnership to develop off-the-shelf cell therapies. Novo Nordisk will fund technology development at Evotec's facilities, with an option for exclusive rights in a specific therapeutic area. Evotec will receive R&D funding, upfront, milestone, and royalty payments.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:40 am

ABVX

Abivax SA will present new data on its lead drug candidate, obefazimod, at the UEG Week 2024, highlighting its potential in treating ulcerative colitis. The presentation will focus on Phase 2b trial data, suggesting obefazimod as a promising once-daily oral therapy.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:38 am

PYPL

PayPal is expanding its cryptocurrency services to U.S. business account holders, allowing them to buy, sell, and hold digital assets, except in New York State. This move is part of PayPal's strategy to enhance cryptocurrency utility for merchants. The company has previously launched a stablecoin, PayPal USD, and continues to see interest from investors like Ark Invest.

Portfolio Pulse from Aniket Verma

September 26, 2024 | 3:54 am

BTC-USD

ETH-USD

Worldcoin (WLD) surged over 10% amid news of OpenAI's transition to a for-profit model, with CEO Sam Altman receiving equity. This contrasts with declines in Bitcoin and Ethereum. Despite privacy concerns and bans in several countries, WLD saw increased trading volume.

Portfolio Pulse from Aniket Verma

September 26, 2024 | 3:16 am

MU

NVDA

SK Hynix's shares surged over 9% as it began mass production of advanced HBM3E chips, driven by AI demand. The company, a key supplier to NVIDIA, plans to deliver these chips by year-end. This positions SK Hynix ahead in the competitive AI-driven market.

Portfolio Pulse from Kaustubh Bagalkote

September 26, 2024 | 3:10 am

COST

DKNG

META

MU

TSLA

Meta Platforms, DraftKings, Costco, Micron Technology, and Tesla are gaining attention from investors due to recent developments. Meta announced new products, DraftKings benefited from positive sector guidance, Costco is expected to discuss its membership fee increase, Micron beat revenue estimates, and Tesla is returning to the Paris Motor Show.

Portfolio Pulse from Benzinga Neuro

September 26, 2024 | 2:04 am

BTCUSD

Kamala Harris has reinforced her support for emerging technologies, including blockchain and AI, as part of her economic proposals. This aligns with her goal to boost America's industrial strength. Her stance comes amid increased focus on cryptocurrencies during the election season.

Portfolio Pulse from Aniket Verma

September 26, 2024 | 1:31 am

AMZN

PDD

WMT

BofA Securities anticipates strong online spending this holiday season, with Amazon and Walmart well-positioned to benefit. Consumers are focused on value, with 52% planning to increase online spending. Walmart leads in online groceries, while Amazon sees high spending intentions.

Portfolio Pulse from Erica Kollmann

September 25, 2024 | 10:12 pm

LLY

Eli Lilly is taking action against compounding pharmacies selling knockoff weight loss drugs, citing safety concerns. The company is seeking medical records to build a case against these businesses. Eli Lilly's stock has soared due to high demand for its weight loss drugs, despite supply constraints.

Portfolio Pulse from Chris Katje

September 25, 2024 | 10:01 pm

NVO

Novo Nordisk A/S (NYSE:NVO) products are not only aiding in weight loss and diabetes control but may also help treat addiction. The stock has shown strong support at the $123 level, driven by trader psychology, including seller's remorse and buyer's anxiety, which can lead to price rallies.

Portfolio Pulse from Mark Putrino

September 25, 2024 | 9:47 pm